Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01a96e8bbea00eeaa0b50c2a0c000dba |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
filingDate |
1999-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cd27fb03ab26231986b0beebdc1603d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e549ebd59635319c5be06a55a3a3f4d |
publicationDate |
1999-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2402599-A1 |
titleOfInvention |
Programmed cell death and caspase-12 |
abstract |
This invention relates to nucleic aids according caspase-12, proteins encoded by camp-12 nucleic acids proteins, and hosts transformed with vectors. Caspase-12 is a member of the caspase family, which also includes mammalian interleukin-1.beta.-converting enzyme (ICE). Caspases are thought to carry out the execution phase of apoptosis in a cascade of proteolytic events. The invention also to the use of caspsae-12 to induce programmed cell death. |
priorityDate |
1998-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |